TP53 and endometrium adenocarcinoma: In the injected p53/Brca1 mice, we found that ~half of them developed various endometrial malignancies, including the hyperplasia of endometrial cells (Figure 4A), endometrial adenocarcinoma (Figure 4B), and leiomyosarcoma (Figure 4C).